Outset Medical Inc (OM) Quote

OM...........https://stockcharts.com/h-sc/ui?s=OM&p=W&b=5&g=0&id=p86431144783

OM.....................https://stockcharts.com/h-sc/ui?s=OM&p=W&b=5&g=0&id=p86431144783

OM...................https://stockcharts.com/h-sc/ui?s=OM&p=W&b=5&g=0&id=p86431144783

OM..............................https://stockcharts.com/h-sc/ui?s=OM&p=W&b=5&g=0&id=p86431144783

OM..................https://stockcharts.com/h-sc/ui?s=OM&p=W&b=5&g=0&id=p86431144783

Current Outset Medical shareholders who have continuously held Outset Medical shares since prior to August 1, 2022, can seek corporate reforms, the return of funds back to company coffers, and a court approved incentive award at no cost to them.

If you would like to learn more about this matter at no cost to you, you are encouraged to visit https://grabarlaw.com/the-latest/outsetmedical-shareholder-investigation/, contact Joshua H. Grabar at jgrabar @FH-6085.

OM............................https://stockcharts.com/h-sc/ui?s=OM&p=W&b=5&g=0&id=p86431144783

OM...................................https://stockcharts.com/h-sc/ui?s=OM&p=W&b=5&g=0&id=p86431144783

anOMalous DUMPING!!!

oh wow it’s actually up today

CLASS ACTION DUMPING

OM new 52 week low

OM new 52+week low

axiOMatic DUMPING!

uncOMprOMising DUMPING!!!

OM new 52+week low

OMinous DUMPING!

OMnidirectional DUMPING!!!

OMnipresent DUMPING

incOMparable DUMPING

indOMitable DUMPING

OM new 52 week low

incOMparable DUMPING!!!

bOMbastic DUMPING!!

OM new 52+weeklow

incOMprehensible DUMPING

incOMpetent DUMPING!!!

OM new 52 low

cOMplete DUMPING!

OMnivorous DUMPING!

OM new 52 week low

OMnipotent DUMPING!!!

OM new 52 week low

OMg SO MUCH DUMPING

UNFINISHED DUMPING

OM new 52 week low

OM a money losing company in the dialysis sector

OM...HERE WE GO

OM....HERE WE GO

OM...READY COME OUT OF THE GATE

OM...TICKITY.... TICKITY TOK...THIS STOCK IS ABOUT TO ROCK!!!

OM CONSOLIDATION THEN WE FLY TO TARGET!!

OM..2.84 INCOMING

OM...MONSTER MOVE IN COMING

OM...BREAKING NEW HIGH

OM..MOVING FAST

OM....BREAKING

OM...RUNNNING

Form 10-K
Filing Date Feb 23, 2022
Document Date Dec 31, 2021
Form Description Annual report which provides a comprehensive overview of the company for the past year
Filing Group Annual Filings
Company Outset Medical, Inc.
Issuer Outset Medical, Inc.

https://investors.outsetmedical.com/sec-filings/sec-filing/10-k/0000950170-22-001769

https://investors.outsetmedical.com/node/8186/html

Outset Medical to Present at 42nd Annual Cowen Health Care Conference


SAN JOSE, Calif.--(BUSINESS WIRE)--Feb. 22, 2022-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Tuesday, March 8, 2022 at 11:50am PT / 2:50pm ET.

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.


About Outset Medical, Inc.


Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

https://investors.outsetmedical.com/news-releases/news-release-details/outset-medical-present-42nd-annual-cowen-health-care-conference